← Back to Dashboard

DRREDDY Dr. Reddy's Laboratories Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 0.77%
₹ 1,206.00
-1.40%
1-year price · range ₹1,167–₹1,368

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Covering
Price rose (+1.1%) on short-covering (OI down -1.2%), suggesting a temporary relief bounce rather than new buyers.

Analysis what the data is telling us about DRREDDY

In the last completed session, Dr. Reddy's Laboratories Ltd. closed +1.07% with futures open interest moving -1.2%. That combination — price rising while OI shrinks — is classified as Short Covering. It typically reflects existing short sellers closing positions, not fresh buying. Short-covering rallies can be sharp but tend to fade without follow-through demand. The stock's option PCR sits at 0.45, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,260 sits 4.5% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Dr. Reddy's Laboratories Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Dr. Reddy's Laboratories Ltd. points to a supportive setup at the next open. The next scheduled earnings report is on 2026-07-22, with the consensus EPS estimate at ₹9.13444. Earnings days routinely override positioning signals — keep an eye on the calendar.

F&O Positioning EOD derivatives setup

Buildup Class
Short Covering
bias: bullish
Futures OI
17,431,250
-208750 (-1.2%)
Option PCR (OI)
0.45
heavy call writing
Max Pain Strike
₹ 1,260
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,223.10
yesterday's EOD close
Index Contribution
-0.011 pp
contribution to Nifty
Traded Volume
2,182,513
live shares traded today
Upcoming Earnings
2026-07-22
EPS est: 9.13444

Technical Snapshot from 400 sessions of price history

RSI (14)
34.9
neutral momentum
52-Week High
₹ 1,414.90
-13.6% from high
52-Week Low
₹ 1,148.40
+6.5% above low
200-DMA
₹ 1,266.39
-3.4% · below trend
50-DMA
₹ 1,297.28
-5.7% from 50-DMA
1-Year Return
-3.0%
1M -3.9%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
23.4
price / earnings
P/B
2.7
price / book
ROE
11.8%
return on equity
Market Cap
₹ 100,425 Cr
total market value
Dividend Yield
0.66%
trailing yield
EPS (TTM)
₹ 51.48
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-07-28 · spot 1,223 · EOD 2026-07-20

Option writers expect range between 1,200 and 1,400+14.5% upside, -1.9% downside.
upside-skewed
Call OI (writers) Strike Put OI (writers)
13,125
IV 50% Δ 0.79 θ -1.9 ν 0
1160
210,625 +35k
IV 34% Δ -0.12 θ -0.8 ν 0
120,625 +3k
IV 49% Δ 0.76 θ -2.0 ν 1
1170
195,625 -10k
IV 34% Δ -0.16 θ -1.0 ν 0
26,250 +5k
IV 47% Δ 0.73 θ -2.0 ν 1
1180
223,125 -7k
IV 34% Δ -0.21 θ -1.1 ν 0
0
IV 218% Δ 0.60 θ -10.3 ν 1
1190
351,875 -37k
IV 34% Δ -0.26 θ -1.3 ν 1
244,375 -31k
IV 39% Δ 0.66 θ -1.9 ν 1
1200 S
896,875 +29k
IV 33% Δ -0.32 θ -1.4 ν 1
145,000 -64k
IV 38% Δ 0.60 θ -1.9 ν 1
1210
291,250 +20k
IV 33% Δ -0.39 θ -1.4 ν 1
461,250 +29k
IV 38% Δ 0.54 θ -1.9 ν 1
1220
461,250 +61k
IV 33% Δ -0.46 θ -1.5 ν 1
496,250 -18k
IV 37% Δ 0.48 θ -1.9 ν 1
1230
603,750 +29k
IV 33% Δ -0.53 θ -1.4 ν 1
798,750 -165k
IV 37% Δ 0.41 θ -1.8 ν 1
1240
486,250 -13k
IV 32% Δ -0.60 θ -1.4 ν 1
1,040,625 -126k
IV 37% Δ 0.36 θ -1.8 ν 1
1250
703,750 -28k
IV 32% Δ -0.67 θ -1.2 ν 1
675,625 +26k
IV 37% Δ 0.30 θ -1.6 ν 1
1260 MP
528,125 -21k
IV 32% Δ -0.73 θ -1.1 ν 1
553,750 -75k
IV 38% Δ 0.25 θ -1.5 ν 1
1270
334,375 -77k
IV 32% Δ -0.79 θ -0.9 ν 0
686,250 +50k
IV 38% Δ 0.21 θ -1.4 ν 0
1280
168,750 -1k
IV 30% Δ -0.85 θ -0.6 ν 0

Chain Interpretation

Spot Underlying 1,223.10
Key Resistance (R) 1,400
Key Support (S) 1,200
Max Pain Strike (MP) 1,260
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for DRREDDY options · 2026-07-28 expiry

Underlying: DRREDDY · Spot: ₹ 1,223.10 · Expiry: 2026-07-28 · Lot: 625

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

DRREDDY — frequently asked questions

What is the Dr. Reddy's Laboratories Ltd. share price today?

DRREDDY is trading at ₹1,206.00 (-1.40% vs previous close), per the latest update on this page.

What is the P/E ratio of Dr. Reddy's Laboratories Ltd.?

DRREDDY (Dr. Reddy's Laboratories Ltd.) has a trailing twelve-month P/E ratio of 23.4.

What is the market cap of Dr. Reddy's Laboratories Ltd.?

DRREDDY has a market capitalisation of approximately ₹100,425 crore.

What is the ROE of Dr. Reddy's Laboratories Ltd.?

DRREDDY has a return on equity (ROE) of about 11.8%.

Is DRREDDY near its 52-week high?

DRREDDY is trading -13.6% from its 52-week high of ₹1,414.90 as of 2026-07-20.

What is the RSI of DRREDDY?

The 14-day RSI of DRREDDY is 34.9, which is considered neutral.

Is DRREDDY above its 200-day moving average?

DRREDDY is trading below its 200-DMA of ₹1,266.39 (-3.4% away).

What is the F&O buildup in DRREDDY?

The latest end-of-day derivatives data classifies DRREDDY as Short Covering (bias: bullish), based on the day's combined price and open-interest change.

What is the max pain and PCR for DRREDDY options?

DRREDDY's option-chain max pain strike is ₹1,260 and its put-call ratio (OI) is 0.45, from the latest end-of-day option chain.

Are FIIs or big investors buying DRREDDY?

Strota tracks every bulk and block deal in DRREDDY with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.